<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02822833</url>
  </required_header>
  <id_info>
    <org_study_id>04</org_study_id>
    <nct_id>NCT02822833</nct_id>
  </id_info>
  <brief_title>The Role of Indocyanine Green to Identify Sentinel Lymph Node in Uterine Cancer</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ankara University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ankara University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endometrial cancer is the most common gynecologic malignancy in developed countries and the
      second one in developing countries following cervical cancer. The primary treatment for
      endometrial cancer involves total hysterectomy and bilateral salpingo-oophorectomy, with
      adjuvant radiotherapy and/or chemotherapy reserved for patients with advanced disease or who
      have risk factors for relapse. The tumor is confined to the uterus in 85% of endometrial
      cancers. Hence, it's controversial to perform systematic lymphadenectomy to all patients. The
      primary purpose of the present study is the to investigate the feasibility of sentinel lymph
      node determination in endometrial cancer patients operated via conventional laparoscopy. To
      determine sentinel lymph nodes cervical indocyanine green will be injected prior to the
      surgery. During the surgery using fluorescent imaging systems sentinel lymph nodes will be
      removed and examined by frozen section. Afterwards, systematic pelvic lymphadenectomy will be
      performed. In case of type II endometrial cancer, grade 3, metastatic sentinel lymph nodes or
      macroscopically enlarged paraaortic lymph nodes, paraaortic lymphadenectomy will also be
      performed. The secondary purpose of the study is to compare the conventional laparoscopy in
      sentinel lymph node mapping of endometrial cancer patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity and specificity of sentinel lymph node frozen section</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Unilateral or bilateral sentinel lymph node detection rate by indocyanine green</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Negative and positive predictive values for sentinel lymph node frozen section</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Endometrial Neoplasm</condition>
  <arm_group>
    <arm_group_label>Sentinel lymph node mapping</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sentinel lymph node mapping with indocyanine green injection to cervix in endometrial cancer patients operated laparoscopically</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sentinel lymph node mapping</intervention_name>
    <description>Before laparoscopic hysterectomy and lymphadenectomy procedure for endometrial cancer, Indocyanine green solution will be injected through cervix. Then the surgeon will look for sentinel lymph nodes under fluorescence visualization.</description>
    <arm_group_label>Sentinel lymph node mapping</arm_group_label>
    <other_name>Karl Storz ICG system, to visualize the fluorescence</other_name>
    <other_name>Indocyanine green, PULSION medical systems</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pathologic diagnosis of endometrial cancer

          -  Clinical stage I or II

        Exclusion Criteria:

          -  Contraindications for operation (hematological or coagulation disorders)

          -  Advanced stage

          -  Pregnancy or puerperium

          -  Fertility preserving surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Salih Taşkın, Assoc. Prof.</last_name>
    <phone>+903125956405</phone>
    <email>salihtaskin@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ankara University School of Medicine Department of Ob&amp;Gyn</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Salih Taşkın, Assoc. Prof.</last_name>
      <phone>+903125956405</phone>
      <email>salihtaskin@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Salih Taşkın, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fırat Ortaç, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2016</study_first_submitted>
  <study_first_submitted_qc>July 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 4, 2016</study_first_posted>
  <last_update_submitted>September 11, 2016</last_update_submitted>
  <last_update_submitted_qc>September 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ankara University</investigator_affiliation>
    <investigator_full_name>salih taskin</investigator_full_name>
    <investigator_title>Assoc. Prof.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometrial Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

